The U.S.’ move to lock up raw materials and supplies for Pfizer’s COVID-19 vaccine could spell trouble for manufacturers working on other shots around the globe. The world’s largest vaccine maker by volume, Serum Institute of India, sees bottlenecks ahead, thanks to a U.S. law blocking exports of certain materials needed to produce COVID-19 shots. The… Read More »
How infectious are people who test positive for Covid-19 but have no symptoms? And what is their contribution to the transmission of live virus? These questions are explored by Allyson Pollock, professor of public health at Newcastle University, who’s always candid and unafraid to say it like it is. She and Newcastle colleague, independent researcher… Read More »
Dive Brief: Aggressively regulating the prices of hospital services could reduce healthcare spending by more than $ 235 billion a year, according to a new study issued by the think tank Rand. The report also examines price transparency and increased market competition among hospitals, and concluded that setting fixed prices would save the most money. … Read More »
Modelling estimates suggest that new HIV infections in the US could be reduced by as much as 94% before 2030, if the current HIV prevention budget is spent more efficiently. Priorities would be linking those diagnosed with HIV to care, ensuring that they receive treatment and getting them to the point of viral suppression. Less… Read More »
One of the biggest mysteries of COVID-19 has been why some people experience no symptoms from the illness, while others fall severely ill and die. The answer may be in the genes, a new joint British and Australian study suggests. Researchers from the University of Queensland, Monash University and the University of Edinburgh studied the… Read More »